Interferon oculentum

Interferon oculentum

  • CN 100,463,693 C
  • Filed: 09/17/2004
  • Issued: 02/25/2009
  • Est. Priority Date: 09/17/2004
  • Status: Active Grant
First Claim
Patent Images

1. interferon eye ointment that is used for the treatment of the eye part disease due to the viral infection, contain the interferon solution and the eye pasting substrate of medicinal active ingredient interferon, contain alpha-interferon, human albumin, sodium hydrogen phosphate, sodium dihydrogen phosphate and sodium chloride in the wherein said interferon solution;

  • Contain Yellow Vaselin in the described eye pasting substrate, liquid paraffin, lanoline and emulsifying agent;

    Each composition proportion is;

    Interferon solution;

    interferon is 1.0 * 10 by biological activity volume ratio in its component 5IU/ml~

    3.0 * 10 8IU/ml, other by weight volume ratio be;

    human albumin 0.1%~

    2.0%, sodium hydrogen phosphate 0.5%~

    1.2%, sodium dihydrogen phosphate 0.2%~

    0.8%, sodium chloride 0.1%~

    0.8%;

    Eye pasting substrate;

    by weight, it consists of;

    Yellow Vaselin 60%~

    90%, liquid paraffin 5%~

    20%, lanoline 5%~

    20%, emulsifying agent polyoxyethylene sorbitan monoleate 0.02%~

    2.0%;

    AndIn the described interferon eye ointment, interferon;

    eye pasting substrate=1.0 * 10 5IU~

    5.0 * 10 8IU;

    100g.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×